Antimicrobial susceptibility of Stenotrophomonas maltophilia from United States medical centers (2019–2023)
Antimicrobial Agents and Chemotherapy · 02.04.2025 · 69 (4)
DOI: 10.1128/aac.00124-25 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 02.04.2025. Verfasst von Helio S Sader und 3 weiteren Autor:innen. Beteiligte Einrichtung: Element Iowa City (JMI Laboratories), North Liberty, Iowa, USA. Hauptthemen laut MEDLINE: Stenotrophomonas maltophilia, Anti-Bacterial Agents. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
We evaluated the antimicrobial susceptibility of 1,400 clinical isolates of Stenotrophomonas maltophilia consecutively collected from United States medical centers in 2019–2023. Aztreonam-avibactam (MIC 50/90 , 2/4 µg/mL; 99.6% inhibited at ≤8 µg/mL) was the most active compound, followed by trimethoprim-sulfamethoxazole (MIC 50/90 , ≤0.12/0.5 µg/mL; 96.9% susceptible), minocycline (MIC 50/90 , 0.5/2 µg/mL; 89.2% susceptible), and levofloxacin (MIC 50/90 , 1/8 µg/mL; 78.9% susceptible). Aztreonam-avibactam retained potent activity against isolates not susceptible to trimethoprim-sulfamethoxazole, minocycline, and/or levofloxacin (99.3%–100.0% inhibited at ≤8 µg/mL).
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Element Iowa City (JMI Laboratories), North Liberty, Iowa, USA.
ORCID-Profile: Helio S Sader
Zitieren
APA
Sader, H. S., Castanheira, M., Arends, S. J. R., & Doyle, T. B. (2025). Antimicrobial susceptibility of Stenotrophomonas maltophilia from United States medical centers (2019–2023). Antimicrobial Agents and Chemotherapy, 69(4). https://doi.org/10.1128/aac.00124-25
Vancouver
Sader HS, Castanheira M, Arends SJR, Doyle TB. Antimicrobial susceptibility of Stenotrophomonas maltophilia from United States medical centers (2019–2023). Antimicrobial Agents and Chemotherapy. 2025;69(4). doi:10.1128/aac.00124-25
BibTeX
@article{Sader2025,
author = {Sader, Helio S and Castanheira, Mariana and Arends, S J Ryan and Doyle, Timothy B},
title = {Antimicrobial susceptibility of Stenotrophomonas maltophilia from United States medical centers (2019–2023)},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2025},
volume = {69},
number = {4},
doi = {10.1128/aac.00124-25}
}
EUVIMED